Growth Metrics

Inogen (INGN) Cash from Investing Activities Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn 3.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.09%
Dec 31, 2025 -113.14%
Sep 30, 2025 -126.89%
Jun 30, 2025 -82.39%
Mar 31, 2025 84.84%
Dec 31, 2024 179.55%
Sep 30, 2024 100.67%
Jun 30, 2024 -2,191.85%
Mar 31, 2024 21.43%
Dec 31, 2023 159.45%
Sep 30, 2023 -863.05%
Jun 30, 2023 -111.08%
Mar 31, 2023 -322.26%
Dec 31, 2022 43.90%
Sep 30, 2022 -512.05%
Jun 30, 2022 210.57%
Mar 31, 2022 -510.95%
Dec 31, 2021 33.18%
Sep 30, 2021 114.48%
Jun 30, 2021 45.23%
Mar 31, 2021 -88.92%
Dec 31, 2020 -158.89%
Sep 30, 2020 89.18%
Jun 30, 2020 -257.31%
Mar 31, 2020 228.08%
Dec 31, 2019 1,472.60%
Sep 30, 2019 -674.00%
Jun 30, 2019 144.65%
Mar 31, 2019 -16.01%
Dec 31, 2018 165.77%
Sep 30, 2018 -63.33%
Jun 30, 2018 2.87%
Mar 31, 2018 -59.07%
Dec 31, 2017 -452.91%
Sep 30, 2017 45.48%
Jun 30, 2017 -623.68%
Mar 31, 2017 -499.68%
Dec 31, 2016 -15.55%
Sep 30, 2016 -56.78%
Jun 30, 2016 90.93%
Mar 31, 2016 123.32%
Dec 31, 2015 90.24%
Sep 30, 2015 -77.51%
Jun 30, 2015 -317.25%
Mar 31, 2015 -25.15%
Dec 31, 2014 -33.83%
Sep 30, 2014 28.74%
Jun 30, 2014 22.23%
Mar 31, 2014 9.55%